News & Events

Nov 20 // Taliaz Awarded $2.7 Million EU Horizon 2020 Grant

Nov 20 // Taliaz Awarded $2.7 Million EU Horizon 2020 Grant

European Union Horizon 2020 Grants are financial funding projects that encourage scientific innovation in Europe, specifically for projects which improve society. The grant was provided to Taliaz to help it expand  its clinical research to Europe and further enhance mental health, specifically focusing on how its product can assist in combating, treating, and managing patient depression in several EU countries.

lire plus
Oct 20 // Hillel’s Tech Corner with Taliaz in the Jerusalem Post

Oct 20 // Hillel’s Tech Corner with Taliaz in the Jerusalem Post

Since 2015, an Israeli start-up called Taliaz is overcoming this challenge. Neuroscientist Dr. Dekel Taliaz, together with his brother Oren, founded the company and gave it the siblings’ family name, Taliaz. Its mission is to empower doctors and patients with artificial intelligence to improve the assessment, management and prescribing success in mental health disorders. In other words, to support doctors to prescribe the right medication the first time and help minimize or remove today’s painful trial and error period.

lire plus
May 20 // Taliaz CEO interviewed in Forbes

May 20 // Taliaz CEO interviewed in Forbes

Taliaz CEO Dr. Dekel Taliaz interviewed in Forbes. “We would be in a very different place if we had better access to up-to-date global medical insights”, he says. “Rather than decision makers relying on outdated or irrelevant statistics, they would have the power to make flexible decisions based on real-life conditions.”

lire plus
Aug 19 // Taliaz featured in ISRAEL21c

Aug 19 // Taliaz featured in ISRAEL21c

Speaking with ISRAEL21c, a leading American online magazine focused on technological and scientific advances made by researchers in Israel, Taliaz CEO, Dekel Taliaz shares his story on why he founded Taliaz with his brother, Oren.  

lire plus
Apr 19  // Taliaz featured in Forbes

Apr 19 // Taliaz featured in Forbes

Only by combining deep scientific research, genetics, neurological, environmental and clinical data, can we understand these complexities and identify the relevant markers to build prediction models that can offer these patients the best outcome,” says Taliaz CEO Dekel Taliaz, who has a PhD in Neuroscience from the Weizmann Institute. 

lire plus

Contact Us

+972 (0)77 335 2506

hello@predictix.ai

2 Prof. Yehezkel Kaufmann St. Tel Aviv-Yafo, Israel

Get Started

Let's help patients recover sooner with PREDICTIX